An exploratory study of Principal Investigator roles in UK university Proof-of-Concept processes: an Absorptive Capacity perspective

被引:26
|
作者
McAdam, Maura [1 ]
McAdam, Rodney [2 ]
Galbraith, Brendan [3 ]
Miller, Kristel [2 ]
机构
[1] Queens Univ Belfast, Sch Management & Econ, Belfast BT7 1NN, Antrim, North Ireland
[2] Univ Ulster, Sch Mkt Entrepreneurship & Strategy, Newtownabbey BT37 OQB, Antrim, North Ireland
[3] Univ Ulster, Dept Management, Newtownabbey BT37 OQB, Antrim, North Ireland
关键词
TECHNOLOGY-TRANSFER OFFICES; PERFORMANCE; INNOVATION; COMMERCIALIZATION; ENTREPRENEURSHIP; VENTURES; SCIENCE; IMPACT;
D O I
10.1111/j.1467-9310.2010.00619.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
The increasing emphasis on academic entrepreneurship, technology transfer and research commercialisation within UK universities is predicated on basic research being developed by academics into commercial entities such as university spin-off companies or licensing arrangements. However, this process is fraught with challenges and risks, given the degree of uncertainty regarding future returns. In an attempt to minimise such risks, the Proof-of-Concept (PoC) process has been developed within University Science Park Incubators (USIs) to test the technological, business and market potential of embryonic technology. The key or the pivotal stakeholder within the PoC is the Principal Investigator (PI), who is usually the lead academic responsible for the embryonic technology. Within the current literature, there appears to be a lack of research pertaining to the role of the PI in the PoC process. Moreover, Absorptive Capacity (ACAP) has emerged within the literature as a theoretical framework or lens for exploring the development and application of new knowledge and technology, where the USI is the organisation considered in the current study. Therefore, the aim of this paper is to explore the role and influence of the PI in the PoC process within a USI setting using an ACAP perspective. The research involved a multiple case analysis of PoC applications within a UK university USI. The results demonstrate the role of the PI in developing practices and routines within the PoC process. These practices and processes were initially tacit and informal in nature but became more explicit and formal over time so that knowledge was retained within the USI after the PIs had completed the PoC process.
引用
收藏
页码:455 / 473
页数:19
相关论文
共 41 条
  • [1] Proof of concept processes in UK university technology transfer: an absorptive capacity perspective
    McAdam, Rodney
    McAdam, Maura
    Brown, Valerie
    [J]. R & D MANAGEMENT, 2009, 39 (02) : 192 - 210
  • [2] Investigator-initiated trial of efalizumab for atopic dermatitis: A proof-of-concept study in adults
    Magliocco, Melissa
    Lipets, Irina
    Dombrovskiy, Viktor
    Gottlieb, Alice
    [J]. CLINICAL IMMUNOLOGY, 2007, 123 : S166 - S166
  • [3] Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study
    Chang, Anne Lynn S.
    Tran, Duy C.
    Cannon, John G. D.
    Li, Shufeng
    Jeng, Mark
    Patel, Roma
    Van der Bokke, Lindsay
    Pague, Alana
    Brotherton, Richard
    Rieger, Kerri E.
    Satpathy, Ansuman T.
    Yost, Kathryn E.
    Reddy, Sunil
    Sarin, Kavita
    Colevas, A. Dimitrios
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (02) : 564 - 566
  • [4] The role of a Proof of Concept Center in a university ecosystem: an exploratory study
    Maia, Catarina
    Claro, Joao
    [J]. JOURNAL OF TECHNOLOGY TRANSFER, 2013, 38 (05): : 641 - 650
  • [5] The role of a Proof of Concept Center in a university ecosystem: an exploratory study
    Catarina Maia
    João Claro
    [J]. The Journal of Technology Transfer, 2013, 38 : 641 - 650
  • [6] Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
    Depommier, Clara
    Everard, Amandine
    Druart, Celine
    Plovier, Hubert
    Van Hul, Matthias
    Vieira-Silva, Sara
    Falony, Gwen
    Raes, Jeroen
    Maiter, Dominique
    Delzenne, Nathalie M.
    de Barsy, Marie
    Loumaye, Audrey
    Hermans, Michel P.
    Thissen, Jean-Paul
    de Vos, Willem M.
    Cani, Patrice D.
    [J]. NATURE MEDICINE, 2019, 25 (07) : 1096 - +
  • [7] Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
    Clara Depommier
    Amandine Everard
    Céline Druart
    Hubert Plovier
    Matthias Van Hul
    Sara Vieira-Silva
    Gwen Falony
    Jeroen Raes
    Dominique Maiter
    Nathalie M. Delzenne
    Marie de Barsy
    Audrey Loumaye
    Michel P. Hermans
    Jean-Paul Thissen
    Willem M. de Vos
    Patrice D. Cani
    [J]. Nature Medicine, 2019, 25 : 1096 - 1103
  • [8] Pembrolizumab with or without vismodegib for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study
    Chang, A.
    Tran, D. C.
    Cannon, J.
    Li, S.
    Jeng, M.
    Rieger, K.
    Sarin, K. Y.
    Yost, K.
    Satpathy, A.
    Reddy, S.
    Colevas, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S92 - S92
  • [9] A spatial analysis of the robustness of the private kill abattoir network in the UK: proof-of-concept study
    Franks, Jeremy R. R.
    Hepburn, Jessica
    Peden, Rachel S. E.
    [J]. BRITISH FOOD JOURNAL, 2023, 125 (08): : 2721 - 2736
  • [10] Using smartphones to disseminate home learning support to primary caregivers: An exploratory proof-of-concept study
    Cohrssen, Caroline
    Richards, Ben
    Wang, Rhoda
    [J]. INFANT AND CHILD DEVELOPMENT, 2023, 32 (02)